Enliven Therapeutics (ELVN) Q2 2021 Earnings

6AugExpected
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-2.96
-2.16
-1.36
-0.56

Details

Expected EPS
-0.9109
Actual EPS
-2.96
Surprise EPS
-2.05
Surprise Percent
+224.95%

Description

Enliven Therapeutics (ELVN) has reported earnings of -2.96 per share for Q2 2021.

0 Comments

Share your thoughts